Healthcare & Life Sciences
NewLimit
United Statesnewlimit.com
NewLimit is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About NewLimit
NewLimit is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
NewLimit develops medicines to reverse cellular aging by using AI to design transcription-factor payloads that restore youthful function in aged cells, with initial therapeutic programs targeting the liver, immune system, and vasculature.
Explore NewLimit's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.